BRINGING CONTINUOUS DATA TO THERAPY MANAGEMENT
Injectsense exists at the intersection of advanced semiconductor technology and medical systems.
We develop implant-based digital health systems to provide medical staff with continuous long-term data for improved therapy management.
Combining the Best of Microelectronics and Medical Devices
Injectsense stands apart from other device developers thanks to its deep roots in two worlds: semiconductor and medical systems. We combine years of hands-on engineering experience in advanced microtechnology -- including ultra-low power IC design, telemetry and miniaturization -- with medical market, regulatory, software, and device expertise.
Our cross-functional approach has bridged these domains, yielding a number of innovative patent-pending solutions. Our Silicon Valley technical team has years of design and fabrication experience in semiconductor, wireless communications, and wafer-scale volume manufacture, while our Twin Cities team brings decades of commercial medical system and software development.
Medical Advisory Board
Iqbal "Ike" Ahmed, MD, FSCRC
Moran Eye Center
Jason Bacharach, MD FAAO
California Pacific Medical Center
Antoine Brezin, MD, Ph.D.
Paris Cite University
School of Medicine
Ernesto Collazo, MD, FAAO
John G. Flanagan, Ph.D. FAAO
Berkeley School of Optometry
Richard Lindstrom MD, FAAO
Minnesota Eye Consultants
Stephen Sinclair, MD FAAO
Sinclair Retinal Associates
Kuldev Singh, MD
Arthur Sit, MD, FAAO
Robert Stamper, MD
University of California
Charles Yancy, MD, Ph.D.
West Metro Ophthalmology
Myron Yanoff, MD, FAAO
Chair Emeritus Ophthalmology
Scheie Eye Institute
Partnering with Major Strategics
Injectsense partners with major strategics who understand that autonomous, continuous monitoring of key markers will change the standard of care and improve disease outcomes through evidence-supported therapies.
INJECTSENSE IS FOUNDED
Following extensive experience in semiconductor-based medical device development for a range of major clients and applications, Injectsense co-founders develop the idea for a new in-vivo sensor platform. After soliciting industry feedback to poke holes in the idea, they decide the platform is viable and form the company.
SEED FUNDING SECURED AND DESIGN BEGINS
The company raised significant seed funding, assembled its team of microelectronics and systems experts, and began development.